OKYO — OKYO Pharma Ltd

Nasdaq · Health Care · Biotechnology · CIK 1849296 ·
Last close
$1.71
Market Cap
$89.74M
52W High
$1.79
52W Low
$1.44
ADV30
63,583
Next earnings
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Sep 2025 4,643,837 4,220,378 8,059,143
Mar 2025 3,677,336 1,560,902 9,226,891
Sep 2024 2,828,858 987,199 10,054,490

Balance + Analyst (yfinance extras)

Retained Earnings
$-145,608,778
Inventory
Receivables
$23,414
ST Investments
EBIT TTM
Pretax Income TTM
Interest Exp TTM
Analysts
3

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2025 0 -7,091,897 -4,706,292 3,677,336 9,226,891 -1,810,931
Mar 2024 0 -15,749,732 -16,825,461 1,541,264 7,420,846 -9,490,537
Mar 2023 0 -13,187,200 -13,271,685 5,203,920 7,257,157 -7,695,242

TTM Snapshot

Revenues TTM
NetIncome TTM
OpCashFlow TTM
Assets (Latest)
Forward EPS
$-0.20

Peers — same industry

TickerNameMarket CapLastDaily %
LONA LeonaBio, Inc. $90.84M $9.67
ATRA Atara Biotherapeutics, Inc. $86.59M $9.61
PTHS Pelthos Therapeutics Inc. $94.43M $27.17
EXOZ EXOZYMES INC. $84.03M $9.91
CSBR CHAMPIONS ONCOLOGY, INC. $83.11M $5.99

News headlines (Yahoo Finance, 1h cache)

OKYO Pharma expands scientific advisory board with cornea expert - ICYMI
2026-05-23 12:00 · Yahoo
What Makes OKYO Pharma (OKYO) a New Buy Stock
2026-05-20 16:00 · Yahoo
OKYO Pharma Strengthens Scientific Advisory Board With Marta Sacchetti Appointment
2026-05-19 15:02 · Yahoo
OKYO Pharma adds ophthalmology specialist Marta Sacchetti to Scientific Advisory Board
2026-05-19 13:58 · Yahoo
OKYO Expands Scientific Advisory Board with the Appointment of International Expert Marta Sacchetti, MD, PhD
2026-05-19 11:00 · Yahoo
OKYO CEO and CSO to Present and Leadership Team to Participate at Upcoming Scientific Conferences in May
2026-04-29 11:00 · Yahoo
OKYO Pharma to hold Scientific Advisory Board meeting at ASCRS 2026
2026-04-07 12:40 · Yahoo
OKYO Pharma Announces Scientific Advisory Board Meeting and Urcosimod Data Presentation During ASCRS Annual Meeting
2026-04-07 11:00 · Yahoo
OKYO Pharma Announces Chairman and Founder Acquires Shares
2026-03-19 16:00 · Yahoo
OKYO Pharma Announces Director Acquires Shares
2026-03-19 14:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.